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Objective: To observe the effects of Centella asiatica (C. asiatica) methanolic extract on
a-synuclein aggregation and its expression in rotenone-exposed zebraﬁsh.
Methods: Zebraﬁsh (Danio rerio) were exposed to 5 mg/L rotenone for 28 days and co-
incubated with 2.5, 5.0 and 10.0 mg/mL of C. asiatica methanolic extract. The medium
was changed every 48 h for maintain the concentration of rotenone and extract. After 28
days zebraﬁsh were sacriﬁced on the ice block and protein was isolated from zebraﬁsh
brain for ELISA of dopamine and Western blotting of a-synuclein. Immunohistochem-
istry was conducted to observe the a-synuclein expressions from histopathological
preparation of zebraﬁsh brain. The head were soaked in 10% formaline for less than 24 h
and embedded onto parafﬁn block, then sliced for immunohistochemistry using anti a-
synuclein antibody. We also measured zebraﬁsh motility for 5 min in each week.
Results: C. asiatica has important bioactive compounds such as asiaticoside that has anti-
inﬂammatory and antioxidant properties. It may inhibit cascade reaction due to oxidative
stress induced by rotenone. Decreasing reactive oxygen species proposed probability of
radical attack to a-synuclein protein that caused aggregation and increase of its expression.
The motility of zebraﬁsh was also maintained in C. asiatica groups due to the increasing
dopamine level in rotenone-induced zebraﬁsh. High level of reactive oxygen species inac-
tivated enzyme for dopamine synthesis such as tyrosine hydroxylase, and oxidized dopamine
itself. Oxidized dopamine increased a-synuclein aggregation. Thus, the dopamine level
decreased in rotenone-induced zebraﬁsh, but C. asiatica increased dopamine level.
Conclusions: C. asiatica has a potential to be developed as an anti-Parkinson's disease
treatment due to its capability for minimized the sign of Parkinson's such as a-synuclein
aggregation and expression, increasing motility and dopamine as well.1. Introduction
Parkinson's disease (PD) is a progressive neurodegenerative
disorder caused by genetic and environmental factors. PD is also the
most prevalent neurodegenerativemovement disorder of adults and
occurs sporadically in more than 90% of cases. While the primary
motor deﬁcits in PD arise from progressive death of dopaminergic
substantia nigra neurons, the pathologyof PDbeginspreclinically inlower brainstem nuclei with the appearance of small a-synuclein
containing aggregates (Lewy neurites) [1]. a-Synuclein is an
abundant presynaptic protein that binds to negatively charged
phospholipids [2,3], functions as a soluble n-ethylmaleimide-
sensitive factor attachment protein receptor complex chaperone 3
and contributes to PD pathogenesis [4,5]. a-Synuclein is a 140
amino acid protein, mainly localized in presynaptic terminals in
the brain. a-Synuclein is normally an unstructured and soluble
protein [6]. Although the detailed physiological functions of a-
synuclein are still not clear, recent studies suggest that it plays a
key role in synaptic functions [7]. Clinical diagnosis of PD, in
both clinic treatment and research, relies upon characteristic
symptoms and cardinal signs. The diagnosis of PD presently
depends upon observation of bradykinesia, “lead pipe” rigidity,
resting tremor, and subsequent loss of postural reﬂexes [8]. Theopen access article under the CC BY-NC-ND
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protein may be linked to the pathogenesis of PD. Dopamine and its
oxidation derivatives may inhibit a-synuclein aggregation of non-
covalent binding [9].
One valuable type of animal model for PD is established by
treating animals with PD inducing neurotoxins, 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine, rotenone, and paraquat [10].
These neurotoxins are thought to inhibit mitochondrial
complex I activity leading to oxidative stress, impaired energy
metabolism, proteasome dysfunction, and, eventually,
dopamine neuronal loss [11]. Rotenone is a pesticide that
inhibits mitochondrial complex I activity, thus creating an
environment of oxidative stress in the cell [12].
One of the newest model for PD is the zebraﬁsh or Danio rerio
[13]. According to studies, 70% of protein-coding human genes are
related to zebraﬁsh genes, and 84% of the genes known to be asso-
ciated with human disease have a counterpart in the zebraﬁsh
genome. These ﬁndings highlight the importance of the zebraﬁsh
model in human disease research [14]. Although the molecular
mechanisms involved in PD are not fully understood, much
progress has been made in identifying some pathogenic pathways,
such as inﬂammation, excitotoxicity, mitochondrial dysfunction,
and oxidative stress, that might be involved in ischemic neuronal
death [15]. Centella asiatica (C. asiatica) (local name: pegagan) is a
herbaceous plant that might also have medicinal value. It is being
used in Ayurvedic and traditional medicine preparations to
improve learning and memory [16]. Published data suggest that the
plant extract has nootropic effects [17], protects the brain from age-
related oxidative damage [18], and promotes nerve growth and
neuronal dendritic arborization [19]. Our previous ﬁndings showed
that C. asiatica has anti-inﬂammatory effects in lipopoly
saccharide-treated neuronal cells of rats [20].
In this research we evaluated the expression of a-synuclein
and aggregation formation in rotenone-induced zebraﬁsh treated
by C. asiatica extract. We also analyzed zebraﬁsh motility and
dopamine levels in the brain.
2. Materials and methods
2.1. Subjects
Adultmale and female zebraﬁshwere obtained from commercial
suppliers from Tulungangung, East Java, Indonesia. Zebraﬁsh were
identiﬁed in Hydrology Laboratory of Fishery Faculty of Brawijaya
University. Before treatment, zebraﬁsh were housed in semi-static
60 L tank and reared under standard procedure [21]. Fish were fed
three times daily (Tetra Bit and Color Tropical Flakes, Tetra Sales,
Blacksburg, Germany), and kept on a 14:10 light–dark cycle.
Water temperature was maintained between 24 and 26.5 C. All
procedures were approved by the Committee of Medical Faculty
of Brawijaya University (No. 253/EC/KEPK/03/2014).
2.2. Collection of plant material and extraction
C. asiatica was gained from Materia Medica, Batu, Malang,
Indonesia. The aerial part (leaves and branches above ground)
was washed and dried. Dried powder of C. asiatica (100 g) was
diluted in 900 mL of 96% methanol (maceration) and evaporated
in 67 C. Active compound composition is very important to
know the potential of herbs. One of active compound that used
as both standard quality and biomarker for C. asiatica is asiat-
icoside. The asiaticoside level in the extract was then measuredas one of biomarker of C. asiatica by liquid chromatography-
mass spectrometry (Thermo Scientiﬁc, Accela).
2.3. Rotenone and C. asiatica treatment
The used concentrations of rotenone (Sigma 8875) were
based on explorative experiment. We used 2 mg/L rotenone and
had no signiﬁcantly effect on adult zebraﬁsh. We used 2, 5 and
10 mg/L rotenone for 28 days exposure. Finally, we found that
the appropriate concentration was 5 mg/L. Rotenone concentra-
tion at 2 mg/L was found to have no effects on an explorative
zebraﬁsh motility and rotenone 10 mg/L caused ﬁsh death after
48 h (data not shown). So we used 5 mg/L concentration because
it had signiﬁcant effects and the zebraﬁsh were still alive until 4
weeks. Five ﬁsh were placed in 3 tank (25 cm × 16 cm × 12 cm)
for each group, fed three times daily and the medium was
changed every 48 h. All ﬁsh were reared under a photoperiod of
14:10 (dark: light). Methanolic extract of C. asiatica was added
in various concentrations (2.5, 5.0 and 10.0 mg/mL) in the same
time with rotenone for 28 days.
2.4. Motility observation
Dysfunction of locomotor activity is clinical syndrome for
PD. One of them is bradykinesia (decreasing locomotor activ-
ity). The locomotor activity of adult zebraﬁsh was assessed in a
2 L tank (L × W × H: 25.0 cm × 16.5 cm × 12.5 cm) ﬁlled with
2 L water system. Normal behavior of ﬁsh is to swim back and
forth along the length of the tank. Simple observation was used
to determine the locomotor activity of adult zebraﬁsh. Three
vertical lines were drawn on the tank at equal distances, dividing
the tank into four zones (the length of each zone was 6.25 cm).
Locomotor activity was measured for 5 min by counting the
number of lines that adult zebraﬁsh crossed. Therefore, the total
distance that the adult zebraﬁsh traveled was in direct proportion
to the total number of lines that the ﬁsh crossed. The locomotor
activity was calculated by the total number of lines that the
zebraﬁsh crossed, divided by time, and expressed in the number
of crossed lines/5 min (modiﬁed [22]).
2.5. Dopamine measurement by ELISA
Zebraﬁsh were euthanized using the standard National In-
stitutes of Health recommended methods by submersion in ice
water (5 parts ice/1 part water, 0–4 C) for at least 10 min
following cessation of opercular (i.e., gill) movement. The head
part was then extracted to get the protein and dopamine level
was measured by ELISA method (Fast Track procedure base on
LDN's technology). The samples of each group were gained
from three heads of zebraﬁsh.
2.6. Western blotting
2.6.1. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis
a-Synuclein protein isolated from heads of zebraﬁsh was
added by reducing sample buffer and heated at 100 C for 3 min.
Cooled samples were injected into the wells which is 20 mL for
each well. The samples (20 mg) were ran in 30 mA and 130 V
until reach 0.5 cm from the bottom of the plate. The gel was
stained with EtBr and destained for 20 min. After transferring
the gel to nitrocellulose, the membrane was rinsed and washed
Figure 2. The standard curve of asiaticoside.
Figure 3. Mean of zebraﬁsh motility measured every week for each group.
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Tween20 (pH 7.5) for 2 min on shaker at room temperature
(RT). The membrane was incubated for 1 h in blocking solution
(5% casein in 0.05% Tween20-PBS, pH 7.5) at RT on shaker.
The band corresponding to tyrosine hydroxylase was probed by
incubating the membrane in monoclonal a-synuclein anti-mouse
antibodies (1:1000 dilution, Santa Cruz Biotechnology, Hei-
delbery, Germany Inc.) in the same blocking solution on shaker
for 1 h at RT. After washing three times (5 min per wash) in
washing buffer (0.05% Tween20-/PBS, pH 7.5), a further in-
cubation with secondary antibody, rabbit anti-mouse immuno-
globulin G-alkaline phosphatase, conjugated with alkaline
phosphatase (1:1500 dilution, Santa Cruz Biotechnology, Inc.)
was carried out for 1 h at RT on shaker. The membrane was
washed further three times for 5 min in washing buffer and
incubated at RT in detection buffer (100 mmol/L Tris–/HCl, pH
9.5, containing 100 mmol/L NaCl and 50 mmol/L MgCl2).
Color detection was carried out by incubating the alkaline
phosphatase substrate nitroblue tetrazolium/5-bromo-4-chloro-3-
indolyl phosphate (Boehringer Mannheim, Mannheim, Ger-
many) at RT in the same detection buffer. Reaction was stopped
manually with water [23].
2.6.2. Immunohistochemistry
After 28 days zebraﬁsh were sacriﬁced to obtain the brain by
decapitation of head in ice water. The head was immediately
immersed in formalin buffer before preparing for parafﬁn block.
The head was sliced (without decalciﬁcation) 0.4 mmol/L thick
and prepared for immunohistochemistry. The slide was depar-
afﬁnized and stained based on vendor manual procedure.We used
a-synuclein (Sigma) as primary antibody. The expression of a-
synuclein (brown) was observed in the midbrain area of zebraﬁsh
brain. Each slide was observed in 1000 timesmagniﬁcation for 20
ﬁelds of view in different areas and average data and each group
contained three zebraﬁsh heads (three slides) [24].
2.7. Statistical analysis
All the grouped data were statistically evaluated with SPSS/
10 software. Hypothesis testing methods included One-way
ANOVA followed by least signiﬁcant difference test. P-values
of less than 0.05 were considered to indicate statistical signiﬁ-
cance. All these results were expressed as mean ± SD for six
animals in each group.Figure 1. Ultra-high performance liquid chromatography of sample and stand3. Results
3.1. Asiaticoside level in methanolic extract of
C. asiatica
To analyze the contents of asiaticoside we used liquid
chromatography-mass spectrometry. Based on the standard of
curve formula, we found that biomarker concentration of asiat-
icoside was 2.9 ppm for which the retention time was aroundard for asiaticoside.
C: Control; R: Rotenone; RCA: Rotenone and C. asiatica.
Figure 5. Western blot analysis of protein a-synuclein.
A: Western blot analysis of small protein a-synuclein (14–16 kDa). It showed
that rotenone-induced zebraﬁsh did not expressed this native form, but control
did.Andadministration of 10.0mg/mLshowed the expression of protein but not
5.0 and 2.5mg/mL;B: Protein aggregation ofa-synuclein (more than 250 kDa).
In the rotenone group there were very high expression of a-synuclein in ag-
gregation form. In the control group the aggregation was still found, but the
expression was slightly decreased by C. asiatica administration and at 10 mg/
mL C. asiatica the aggregation was not found; C: Actin expression as control.
Ctr: Control; R: Rotenone; RCA: Rotenone and C. asiatica.
Figure 6. Immunoreactivity of a-synuclein.
Diaminobenzidine staining (brownish) showed that positive reactivity of a-synu
incubation of rotenone and C. asiatica signiﬁcantly decreased the expression
difference (P < 0.05). C: Control; R: Rotenone; RCA: Rotenone and C. asiati
Figure 4. Effect of C. asiatica on the dopamine level in zebraﬁsh treated
with rotenone.
C: Control; R: Rotenone; RCA: Rotenone and C. asiatica. *: Signiﬁcantly
different compared with control (P < 0.05).
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madecassoside for which the retention time was about 0.7 min.
3.2. Motility assessment
To know the effect of rotenone towards locomotor activity
we measured the zebraﬁsh motility for 5 min. The result showed
(Figure 3) that rotenone decreased motility signiﬁcantly starting
from 2nd week and continuing decreased at 3rd week and 4th
week. C. asiatica administration gradually increased the zebra-
ﬁsh motility in a dose dependent manner.
3.3. Dopamine level by ELISA method
Locomotor activity is correlated to the dopamine level in the
brain. The result showed that rotenone signiﬁcantly decreased
dopamine level (P < 0.05) (Figure 4).
Administration of C. asiatica extract increased dopamine
level in a dose dependent manner, higher concentration higher
dopamine level. Interestingly, dopamine level increased signif-
icantly start from concentration 2.5 mg/mL (P = 0.000) and
concentration of 10.0 mg/mL had no signiﬁcant difference to the
control group (P = 0.644). It seems that 10.0 mg/mL could
protect dopaminergic neuron from rotenone destruction and
maintain dopamine levels appropriately.
3.4. Western blotting of a-synuclein
Increasing free radical production in rotenone-induced
zebraﬁsh lead to aggregation form of a-synuclein and adminis-
tration of C. asiatica could prevent the aggregation of a-synu-
clein in rotenone-induced zebraﬁsh (Figure 5). To further
augment our hypothesis that a-synuclein is indeed involved in
rotenone-induced Parkinsonism in zebraﬁsh, we observed a-
synuclein expression by immunohistochemistry (Figure 6). In
this assay the antibody recognized both native and aggregation
form of this protein. Rotenone signiﬁcantly increased the a-clein. The graph showed the quantiﬁcation of a-synuclein expression. Co-
at 5.0 and 10.0 mg/mL. Different letters show the statistical signiﬁcantly
ca. 400×.
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incubation of C. asiatica extract decreased the expression of
protein at concentrations of 5 and 10 mg/mL.
4. Discussion
4.1. Methanolic extract of C. asiatica
The chemical composition of C. asiatica has a very important
role in medicinal and nutraceutical applications and it is believed
due to its biologically active components of triterpenes saponins
[25]. Major bioactive compounds of this plant contain highly
variable triterpenoid saponins, including asiaticoside, asiatic
acid, madecassoside, oxyasiaticoside, centelloside, brahmoside,
brahminoside, thankunoside, isothankuniside and related
sapogenins [26]. Asiatic acid, madecassic acid and
madecassoside, are used as biomarker for quality assessment
of C. asiatica [16]. Many researches showed the
neuroprotective effect of C. asiatica through the antioxidant
and anti-inﬂammatory property of C. asiatica [27].
4.2. Motility assessment
The zebraﬁsh (Danio rerio) has become a widely used model
system for the study of development and gene function.
Zebraﬁsh are vertebrates and therefore more closely related to
humans than other genetic model organisms such as Drosophila
or Caenorhabditis elegans [28]. Many factors suggest that the
zebraﬁsh is a powerful tool for the study of human diseases:
patterning, path ﬁnding and connectivity in the central nervous
system have all been deciphered and correlated with the
human central nervous system [29], touch and behavioral
responses such as movement patterns can be monitored [30].
Rotenone (an inhibitor of mitochondrial reduced form of
nicotinamide-adenine dinucleotide dehydrogenase, a naturally
occurring toxin and commonly used pesticide) appears to
reproduce the neurochemical, neuropathological and behavioral
feature of PD in the rat [24]. One of cardinal sign of Parkinson's
is the rigidity or decreasing ability of movement. Signiﬁcant
decreasing motility of zebraﬁsh started from week 2 (14 days),
which may be caused by decreasing motor nerve conducting
velocity (Figure 3). Binienda et al. [31] proved an association
between dopaminergic damage and peripheral motor nerve
degeneration in an animal model of dopaminergic toxicity.
Peripheral motor nerve dysfunction in rats following a chronic
exposure to rotenone may serve not only as a relevant
experimental model of motor neuropathy but also as a
peripheral marker of dopaminergic neuronal damage to the
central nervous system. Tyrosine hydroxylase, an enzyme that
responsible for dopamine synthesis decreases the
immunoreactivity in rotenone-induced rat [31]. Increase in
dopaminergic neurotransmission leads to increased locomotor
activity and decrease in dopaminergic neurotransmission leads
to decreased locomotor activity [32]. It seems that the
decreasing dopamine level is due to both synthesis of tyrosine
hydroxylase and degradation of dopamine by free radicals.
Methanolic extract of C. asiatica could protect from
decreasing movement ability in rotenone-induced zebraﬁsh. This
condition may be caused by antioxidant and anti-inﬂammatory
property of C. asiatica [33]. Haleagrahara and Ponnusamy [34]
reported that supplementation of C. asiatica decreased lipid
hydroperoxide, protein carbonyl content, and signiﬁcantlyincreased total antioxidant and antioxidant enzyme level in rat
induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Asiatic acid, one of the major components in C. asiatica could
protect rotenone-induced SH-SY5Y cell through the stabiliza-
tion of mitochondrial membrane potential, decreasing voltage-
dependent anion channel both in mRNA and protein level [35].
So, it seems that antioxidant property of C. asiatica could
protect the zebraﬁsh brain from free radical production by
rotenone and decrease auto-oxidation of dopamine neurotrans-
mitter in pre-synapse.
4.3. Dopamine level and a-synuclein aggregation
Rotenone is extremely lipophilic, which crosses biological
membranes easily and independently of transporters (unlike 1-
methyl-4-phenylpyridinium), and it gets into the brain very
rapidly [36]. The chronic, uniform, systemic inhibition of
complex I caused (over a period of days to weeks) selective
degeneration of the substantia nigra dopamine neurons [23,37].
Chronic rotenone exposure leads to mitochondrial respiratory
chain inhibition and dopaminergic neuronal loss. At low
doses, rotenone alters calcium signaling and can induce
oxidative stress, apoptosis and a-synuclein aggregation, which
is also a characteristic of early stages of PD [38]. Dopamine
metabolism through monoamine oxidase and cathecol-O-
methyltransferase contributes to free radical production. These
free radicals could interact with a-synuclein to form aggregate
of a-synuclein. There is evidence that a-synuclein can interact
with the dopamine transporter and tyrosine hydroxylase to
regulate the amount of dopamine synthesized and the storage
of catecholamines into synaptic vesicles [39]. The evidence of
apoptotic in dopaminergic neuron of substantia nigra is
decreased dopamine production.
a-Synuclein is a 14 kDa (140 amino acids) presynaptic
protein abundant in various regions in the brain but its natural
functions are still a matter of speculation [40]. Under
physiological conditions, a-synuclein adopts a random
conformation, natively unfolded. But if exposed to low pH,
high temperature, organic solvents, metal ions, pesticides and
so on, it could aggregate in the cell membrane [41] and form
ion-permeable pores in the lipid bilayer, resulting in the
change of the membrane potential and the subsequent cell dys-
functions [42,43]. The aggregation of a-synuclein in PD always
arrests much attention, it has been supposed to be the primary
events in the pathogenesis of PD [44].
The major active compounds of C. asiatica are known as
asiatic acid, madecassic acid (6-hydroxy-asiatic acid), asiatico-
side, madecassoside, and madasiatic acid, betulinic acid, than-
kunic acid, and isothankunic acid [45,46]. Ethanolic extract of
C. asiatica could inhibit acetylcholinesterase,
butyrylcholinesterase and tyrosinase. These enzymes are
important in PD since these enzymes play a role in
neuromelanin formation in human brain and could be
signiﬁcant in occurrence of dopamine neurotoxicity associated
with neurodegeneration linked to PD [47]. The leaf extract of
C. asiatica growing in China was shown to display
neuroprotection through enhancing phosphorylation of cAMP
response element binding protein in neuroblastoma cells in Ab
(1–42) proteins found within the amyloid plaques occurring in
the brains of Alzheimer's disease patients [48], as we know that
cAMP response element binding protein is important for
brain-derived neurotrophic factor (BDNF) synthesis. BDNF
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research BDNF level were found to be increased by C. asiatica
(data not shown).
Inhibitory activity of the aqueous extract of C. asiatica that
contained 84% of asiaticoside was tested by the radioenzymatic
assay against phospholipase A2, which plays a role in neuro-
inﬂammation [50]. Aqueous extract of C. asiatica on intra
cerebrovascular streptozocin-induced memory associated with
the sporadic type of Alzheimer's disease and pentylenetetrazole-
induced memory loss in rats showed the increasing neuro-
protection through suppression of malondialdehyde and
increasing antioxidant enzyme catalase, superoxide dismutase
and glutathione [51,52]. Another experiment showed that
C. asiatica protects rotenone-induced cells through the stabili-
zation of mitochondrial membrane potential and inhibiting
voltage-dependent anion channel enzyme [34,35]. It seems that
antioxidant and anti-inﬂammatory property of C. asiatica
could protect rotenone-induced zebraﬁsh motility through the
stabilization of dopamine synthesis, availability and its kinetics.
This condition is supported by conserving and protecting a-
synuclein to its native form that inhibit progression of dopami-
nergic neuron degeneration.
Methanolic extract of C. asiatica containing asiaticoside
could improve the ability of movement in rotenone-induced
zebraﬁsh PD model through the stability of dopamine neuro-
transmitter and the decrease of a-synuclein aggregation at con-
centrations of 5 and 10 mg/mL.
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